gliobastoma

13 February, 2024

Organ-on-chip technology validated to evaluate the effect of a drug against glioblastoma

The Calcium Cellular Signaling research group of the IRB Lleida and the University of Lleida, in collaboration with the Aragón Health Research Institute and the University of Zaragoza, have established this technology that allows evaluating the efficacy of drugs in biological models.